A medical communications agency, by the numbers
We have some of the brightest minds in oncology and hematology medical communications. Our global resources, strategic programs, and longstanding relationships with key scientific leaders provide our life science partners with future-focused, evidence-based solutions – all designed to improve clinical decision making and enhance patient outcomes. View our Facts & Figures Infographic.
The power of evidence-based, omnichannel innovation
Helping our partners successfully navigate the complex oncology and hematology marketplace is a critical part of what we do best. That’s why we created D3 – our unique, 3-phase approach provides competitive solutions to your most difficult challenges, every time.
Better decisions start with strategic expertise
We partner with the world’s best
Up-to-date stories, articles, and insights from the TRM Oncology team
Over the years, healthcare providers (HCPs) have changed and expanded the ways in which they communicate. How the pharma industry practices HCP segmentation should now reflect a more value-based approach. This means segmentation should be based not only on how valuable HCPs are to the pharma company (a traditional approach), but also by how the […]
There are several emerging disruptions that, as a pharma marketer, you can’t afford to ignore. These trends are artificial intelligence (which includes machine learning and email automation), personalization as an approach to marketing, digital therapeutic apps and sensors, and telehealth and remote care.
Typically, a pharma marketing strategy is carefully devised, by collecting relevant research data and garnering an understanding of the current market space. It used to be that the marketing message was meant to assume the needs of physicians, and spoke to how the product or service benefited those needs.
Get the latest insights on medical communications and the pharma industry.